Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:52 2026-07-31 EDT			5-day change	1st Jan Change
2,653.45 ^INR	+1.68%		+5.58%	+7.39%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.71B	-	-	-	-
ELI LILLY AND COMPANY	1,024B		A
JOHNSON & JOHNSON	618B		BBB
ABBVIE INC.	443B		AA	-
ROCHE HOLDING AG	349B		AA
NOVARTIS AG	297B		AAA
ASTRAZENECA PLC	264B		A
NOVO NORDISK A/S	209B		A
AMGEN INC.	208B		A
GILEAD SCIENCES, INC.	162B		AA
PFIZER INC.	143B		A
BRISTOL-MYERS SQUIBB COMPANY	133B		A
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
GSK PLC	104B		AA
SANOFI	103B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.57B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.24B		AA
BAYER AG	54.3B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.81B		AA
HALEON PLC	43.08B		AA
Average	222.97B		AA
Weighted average by Cap.			AA